Pitch Competition
新創 Pitch 擂台
新創 Pitch 擂台 Pitch Competition
目標
邀請合作夥伴一同推薦公司/團隊參賽，經書面初選15隊，最終以Pitch Competition形式讓公司/團隊上台展示尖端技術、發展優勢及未來規劃；並廣邀業界專家擔任評 審，針對內容講評、給予意見回饋，期以此提升公司/團隊未來在尋求合作夥伴、增加募資的機會，最終遴選前3名以茲獎勵，將由MIT特邀貴賓進行一對一諮詢，與PwC財務商業顧問諮詢，以及台灣Bio Asia-Taiwan參展證；額外也鏈結北醫體系醫療業師一對一諮詢及市場導入策略，給予各5個獲獎機會；並在美國BIO 2024進行國際行銷推廣。
單位
Academia Sinica (BioTReC), BioTaiwan, BMCC, BPIPO, DCB, NBIC, PwC, TMU, 北市產發局
對象
於中華民國登記之法人（以公司為主，研究機構及醫院為輔）
類型
新藥開發：小分子、蛋白藥、再生醫療、先進醫療；精準健康：精準醫療、智慧醫療
階段
新藥開發：早期開發、臨床前、或早期臨床試驗（ Phase I ）； 精準健康：不限
審議
（50隊）第一階段書審；（ 15隊）第二階段擂台
書審
以進駐諮詢委員、主協辦單位及中心顧問專家為主，每案2-3位審議委員。
面審
以投資者為主，並依主辦單位聯合組成。
評分
整體規劃、技術創新、市場潛力、經營團隊、臨場表現
獎項
（投資青睞獎、潛力新秀獎、技術創新獎） *1；（國際市場獎、臨床驗證獎） *5
時程
3/29企劃確認，4/1-4/12徵案，4/19-5/3書審，5/13公布入選，5/20-24輔導，5/29 10:00-12:30 擂台，16:20-17:00 頒獎
Objective
Our aim is to catalyze innovation and collaboration within the biotech sector by inviting partners to recommend companies/teams for participation in our Pitch Competition. Through a rigorous selection process, we intend to showcase 15 teams with cutting-edge technology, development advantages, and strategic plans. By enlisting industry experts as judges, we seek to provide valuable feedback to enhance the companies' opportunities for collaboration and fundraising. The top 3 teams will receive rewards, including exclusive one-on-one consultations with invited guests from MIT, financial advisory services from PwC, and exhibition certificates for Bio Asia-Taiwan. Additionally, we will offer five additional winning opportunities for personalized consultations with medical system mentors from Taipei Medical University, and tailored market entry strategies. Moreover, we plan to conduct international marketing promotions at BIO 2024 in the United States.
Organizers
Academia Sinica (BioTReC), BioTaiwan, BMCC, BPIPO, DCB, NBIC, PwC, TMU, Taipei City Government (DoED)
Eligibility Criteria:
Legal entities registered in Taiwan (Companies, research institutions & hospitals).
Categories
• Drug Development: Small Molecule, Protein Drugs, Regenerative Medicine, Advanced Medicine
• Precision Health: Precision Medicine, Smart Healthcare
Stages
• Drug Development: Early Development, Preclinical, or Early Clinical Trials (Phase I)
• Precision Health: Open
Evaluation Process:
• Initial Screening: 50 teams undergo a preliminary review.
• Second Round: 15 teams advance to the final stage.
Scoring Criteria
Overall Planning
Technological Innovation
Market Potential
Management Team
Presentation Performance
Awards
Investment Award *1
Potential Award *1
Innovation Award *1
Global Market Award *5
Precision Health Award *5
Timeline
Call for Entries: April 1-12, Initial Screening: April 19-May 3, Selection Announcement: May 13, Counseling Sessions: May 20-24, Pitch Competition: May 29, 10:00-12:30, Award Ceremony: May 29, 16:20-17:00
—— 主辦單位 ——
 |
 |
 |
—— 共同主辦單位 ——
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |